APO Research
Talk to an analyst

APO RESEARCH · REPORT

Formulas for Special Medical Purposes for Diabetes

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Formulas for Special Medical Purposes for Diabetes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchFormulas for Special Medical Purposes for Diabetes Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Formulas for Special Medical Purposes for Diabetes Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Formulas for Special Medical Purposes for Diabetes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Formulas for Special Medical Purposes for Diabetes Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Formulas for Special Medical Purposes for Diabetes Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Formulas for Special Medical Purposes for Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Formulas for Special Medical Purposes for Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Formulas for Special Medical Purposes for Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Formulas for Special Medical Purposes for Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Formulas for Special Medical Purposes for Diabetes include Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Formulas for Special Medical Purposes for Diabetes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Formulas for Special Medical Purposes for Diabetes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Formulas for Special Medical Purposes for Diabetes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Formulas for Special Medical Purposes for Diabetes market size, projected growth trends, production technologies, key applications, and end-use industries.

Formulas for Special Medical Purposes for Diabetes Segment by Company

Abbott Laboratories

Nestlé S.A.

NUTRICIA

Fresenius

Ajinomoto

MeadJohnson

BOSSD

Bayer

EnterNutr

Anhui New Health Biotechnology

Bangsidi Biotechnology

Dongze Special Medical Food

Special Biotechnology

Haisike Pharmaceutical

Xi'an Libang Clinical Nutrition

Formulas for Special Medical Purposes for Diabetes Segment by Type

Gel Food

Porous Food

Powdered Food

Pasty Food

Milky Food

Others

Formulas for Special Medical Purposes for Diabetes Segment by Application

Hospital

Pharmacy

Others

Formulas for Special Medical Purposes for Diabetes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulas for Special Medical Purposes for Diabetes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Formulas for Special Medical Purposes for Diabetes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulas for Special Medical Purposes for Diabetes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Formulas for Special Medical Purposes for Diabetes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Formulas for Special Medical Purposes for Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Formulas for Special Medical Purposes for Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Formulas for Special Medical Purposes for Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Formulas for Special Medical Purposes for Diabetes Industry Trends Table 2. Formulas for Special Medical Purposes for Diabetes Industry Drivers Table 3. Formulas for Special Medical Purposes for Diabetes Industry Opportunities and Challenges Table 4. Formulas for Special Medical Purposes for Diabetes Industry Restraints Table 5. Global Formulas for Special Medical Purposes for Diabetes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Formulas for Special Medical Purposes for Diabetes Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Manufacturers Table 9. Global Formulas for Special Medical Purposes for Diabetes Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Formulas for Special Medical Purposes for Diabetes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Formulas for Special Medical Purposes for Diabetes Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Formulas for Special Medical Purposes for Diabetes Manufacturers, Product Type & Application Table 13. Global Formulas for Special Medical Purposes for Diabetes Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Formulas for Special Medical Purposes for Diabetes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gel Food Table 17. Major Manufacturers of Porous Food Table 18. Major Manufacturers of Powdered Food Table 19. Major Manufacturers of Pasty Food Table 20. Major Manufacturers of Milky Food Table 21. Major Manufacturers of Others Table 22. Global Formulas for Special Medical Purposes for Diabetes Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021-2026) & (k units) Table 24. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2027-2032) & (k units) Table 25. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2021-2026) Table 26. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2027-2032) Table 27. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2021-2026) & (k units) Table 29. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2027-2032) & (k units) Table 30. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2021-2026) Table 31. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Pharmacy Table 34. Major Manufacturers of Others Table 35. Global Formulas for Special Medical Purposes for Diabetes Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021-2026) & (k units) Table 37. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2027-2032) & (k units) Table 38. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2021-2026) Table 39. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2027-2032) Table 40. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2021-2026) & (k units) Table 42. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2027-2032) & (k units) Table 43. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2021-2026) Table 44. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2027-2032) Table 45. Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2021-2026) & (k units) Table 47. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2021-2026) Table 48. Global Formulas for Special Medical Purposes for Diabetes Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Formulas for Special Medical Purposes for Diabetes Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 52. North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 53. Europe Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 55. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 62. Global Formulas for Special Medical Purposes for Diabetes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2021-2026) Table 66. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2027-2032) Table 67. Abbott Laboratories Company Information Table 68. Abbott Laboratories Business Overview Table 69. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 71. Abbott Laboratories Recent Development Table 72. Nestlé S.A. Company Information Table 73. Nestlé S.A. Business Overview Table 74. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 76. Nestlé S.A. Recent Development Table 77. NUTRICIA Company Information Table 78. NUTRICIA Business Overview Table 79. NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 81. NUTRICIA Recent Development Table 82. Fresenius Company Information Table 83. Fresenius Business Overview Table 84. Fresenius Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Fresenius Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 86. Fresenius Recent Development Table 87. Ajinomoto Company Information Table 88. Ajinomoto Business Overview Table 89. Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 91. Ajinomoto Recent Development Table 92. MeadJohnson Company Information Table 93. MeadJohnson Business Overview Table 94. MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 96. MeadJohnson Recent Development Table 97. BOSSD Company Information Table 98. BOSSD Business Overview Table 99. BOSSD Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. BOSSD Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 101. BOSSD Recent Development Table 102. Bayer Company Information Table 103. Bayer Business Overview Table 104. Bayer Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Bayer Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 106. Bayer Recent Development Table 107. EnterNutr Company Information Table 108. EnterNutr Business Overview Table 109. EnterNutr Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. EnterNutr Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 111. EnterNutr Recent Development Table 112. Anhui New Health Biotechnology Company Information Table 113. Anhui New Health Biotechnology Business Overview Table 114. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 116. Anhui New Health Biotechnology Recent Development Table 117. Bangsidi Biotechnology Company Information Table 118. Bangsidi Biotechnology Business Overview Table 119. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 121. Bangsidi Biotechnology Recent Development Table 122. Dongze Special Medical Food Company Information Table 123. Dongze Special Medical Food Business Overview Table 124. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 126. Dongze Special Medical Food Recent Development Table 127. Special Biotechnology Company Information Table 128. Special Biotechnology Business Overview Table 129. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 131. Special Biotechnology Recent Development Table 132. Haisike Pharmaceutical Company Information Table 133. Haisike Pharmaceutical Business Overview Table 134. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 136. Haisike Pharmaceutical Recent Development Table 137. Xi'an Libang Clinical Nutrition Company Information Table 138. Xi'an Libang Clinical Nutrition Business Overview Table 139. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 141. Xi'an Libang Clinical Nutrition Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Formulas for Special Medical Purposes for Diabetes Distributors List Table 145. Formulas for Special Medical Purposes for Diabetes Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Formulas for Special Medical Purposes for Diabetes Product Image Figure 2. Global Formulas for Special Medical Purposes for Diabetes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Formulas for Special Medical Purposes for Diabetes Market Size (2021-2032) & (US$ Million) Figure 4. Global Formulas for Special Medical Purposes for Diabetes Sales (2021-2032) & (k units) Figure 5. Global Formulas for Special Medical Purposes for Diabetes Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Formulas for Special Medical Purposes for Diabetes Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gel Food Image Figure 9. Porous Food Image Figure 10. Powdered Food Image Figure 11. Pasty Food Image Figure 12. Milky Food Image Figure 13. Others Image Figure 14. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2021-2032) Figure 17. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Pharmacy Image Figure 22. Others Image Figure 23. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2021-2032) Figure 26. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2021-2032) Figure 29. North America Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 31. U.S. Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 36. Germany Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 43. China Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 51. Brazil Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Formulas for Special Medical Purposes for Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Formulas for Special Medical Purposes for Diabetes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032) & (US$ Million) Figure 62. North America Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032) & (US$ Million) Figure 64. Europe Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Formulas for Special Medical Purposes for Diabetes Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Formulas for Special Medical Purposes for Diabetes Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Gel Food
  • Porous Food
  • Powdered Food
  • Pasty Food
  • Milky Food
  • Others
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Abbott Laboratories
  • Nestlé S.A.
  • NUTRICIA
  • Fresenius
  • Ajinomoto
  • MeadJohnson
  • BOSSD
  • Bayer
  • EnterNutr
  • Anhui New Health Biotechnology
  • Bangsidi Biotechnology
  • Dongze Special Medical Food
  • Special Biotechnology
  • Haisike Pharmaceutical
  • Xi'an Libang Clinical Nutrition

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Formulas for Special Medical Purposes for Diabetes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Formulas for Special Medical Purposes for Diabetes Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Formulas for Special Medical Purposes for Diabetes Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Formulas for Special Medical Purposes for Diabetes Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Formulas for Special Medical Purposes for Diabetes Market Dynamics
  1. 2.1 Formulas for Special Medical Purposes for Diabetes Industry Trends
  2. 2.2 Formulas for Special Medical Purposes for Diabetes Industry Drivers
  3. 2.3 Formulas for Special Medical Purposes for Diabetes Industry Opportunities and Challenges
  4. 2.4 Formulas for Special Medical Purposes for Diabetes Industry Restraints
3 Formulas for Special Medical Purposes for Diabetes Market by Manufacturers
  1. 3.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Manufacturers (2021-2026)
  3. 3.3 Global Formulas for Special Medical Purposes for Diabetes Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Formulas for Special Medical Purposes for Diabetes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Formulas for Special Medical Purposes for Diabetes Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Formulas for Special Medical Purposes for Diabetes Manufacturers, Product Type & Application
  7. 3.7 Global Formulas for Special Medical Purposes for Diabetes Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Formulas for Special Medical Purposes for Diabetes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Formulas for Special Medical Purposes for Diabetes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Formulas for Special Medical Purposes for Diabetes Tier 1, Tier 2, and Tier 3
4 Formulas for Special Medical Purposes for Diabetes Market by Type
  1. 4.1 Formulas for Special Medical Purposes for Diabetes Type Introduction
  2. 4.1.1 Gel Food
  3. 4.1.2 Porous Food
  4. 4.1.3 Powdered Food
  5. 4.1.4 Pasty Food
  6. 4.1.5 Milky Food
  7. 4.1.6 Others
  8. 4.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Type
  9. 4.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021-2032)
  11. 4.2.3 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2021-2032)
  12. 4.3 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type
  13. 4.3.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2021-2032)
  15. 4.3.3 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2021-2032)
5 Formulas for Special Medical Purposes for Diabetes Market by Application
  1. 5.1 Formulas for Special Medical Purposes for Diabetes Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Application
  6. 5.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021-2032)
  8. 5.2.3 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2021-2032)
  9. 5.3 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application
  10. 5.3.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2021-2032)
  12. 5.3.3 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2021-2032)
6 Global Formulas for Special Medical Purposes for Diabetes Sales by Region
  1. 6.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2021-2032)
  3. 6.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2021-2026)
  4. 6.2.2 Global Formulas for Special Medical Purposes for Diabetes Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region
  1. 7.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region
  2. 7.1.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2021-2026)
  4. 7.1.3 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2027-2032)
  5. 7.1.4 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032)
  8. 7.2.2 North America Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032)
  11. 7.3.2 Europe Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Nestlé S.A.
  8. 8.2.1 Nestlé S.A. Company Information
  9. 8.2.2 Nestlé S.A. Business Overview
  10. 8.2.3 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Portfolio
  12. 8.2.5 Nestlé S.A. Recent Developments
  13. 8.3 NUTRICIA
  14. 8.3.1 NUTRICIA Company Information
  15. 8.3.2 NUTRICIA Business Overview
  16. 8.3.3 NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Portfolio
  18. 8.3.5 NUTRICIA Recent Developments
  19. 8.4 Fresenius
  20. 8.4.1 Fresenius Company Information
  21. 8.4.2 Fresenius Business Overview
  22. 8.4.3 Fresenius Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Formulas for Special Medical Purposes for Diabetes Product Portfolio
  24. 8.4.5 Fresenius Recent Developments
  25. 8.5 Ajinomoto
  26. 8.5.1 Ajinomoto Company Information
  27. 8.5.2 Ajinomoto Business Overview
  28. 8.5.3 Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Portfolio
  30. 8.5.5 Ajinomoto Recent Developments
  31. 8.6 MeadJohnson
  32. 8.6.1 MeadJohnson Company Information
  33. 8.6.2 MeadJohnson Business Overview
  34. 8.6.3 MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Portfolio
  36. 8.6.5 MeadJohnson Recent Developments
  37. 8.7 BOSSD
  38. 8.7.1 BOSSD Company Information
  39. 8.7.2 BOSSD Business Overview
  40. 8.7.3 BOSSD Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BOSSD Formulas for Special Medical Purposes for Diabetes Product Portfolio
  42. 8.7.5 BOSSD Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Formulas for Special Medical Purposes for Diabetes Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 EnterNutr
  50. 8.9.1 EnterNutr Company Information
  51. 8.9.2 EnterNutr Business Overview
  52. 8.9.3 EnterNutr Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EnterNutr Formulas for Special Medical Purposes for Diabetes Product Portfolio
  54. 8.9.5 EnterNutr Recent Developments
  55. 8.10 Anhui New Health Biotechnology
  56. 8.10.1 Anhui New Health Biotechnology Company Information
  57. 8.10.2 Anhui New Health Biotechnology Business Overview
  58. 8.10.3 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
  60. 8.10.5 Anhui New Health Biotechnology Recent Developments
  61. 8.11 Bangsidi Biotechnology
  62. 8.11.1 Bangsidi Biotechnology Company Information
  63. 8.11.2 Bangsidi Biotechnology Business Overview
  64. 8.11.3 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
  66. 8.11.5 Bangsidi Biotechnology Recent Developments
  67. 8.12 Dongze Special Medical Food
  68. 8.12.1 Dongze Special Medical Food Company Information
  69. 8.12.2 Dongze Special Medical Food Business Overview
  70. 8.12.3 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Portfolio
  72. 8.12.5 Dongze Special Medical Food Recent Developments
  73. 8.13 Special Biotechnology
  74. 8.13.1 Special Biotechnology Company Information
  75. 8.13.2 Special Biotechnology Business Overview
  76. 8.13.3 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
  78. 8.13.5 Special Biotechnology Recent Developments
  79. 8.14 Haisike Pharmaceutical
  80. 8.14.1 Haisike Pharmaceutical Company Information
  81. 8.14.2 Haisike Pharmaceutical Business Overview
  82. 8.14.3 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Portfolio
  84. 8.14.5 Haisike Pharmaceutical Recent Developments
  85. 8.15 Xi'an Libang Clinical Nutrition
  86. 8.15.1 Xi'an Libang Clinical Nutrition Company Information
  87. 8.15.2 Xi'an Libang Clinical Nutrition Business Overview
  88. 8.15.3 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Portfolio
  90. 8.15.5 Xi'an Libang Clinical Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Formulas for Special Medical Purposes for Diabetes Value Chain Analysis
  2. 9.1.1 Formulas for Special Medical Purposes for Diabetes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Formulas for Special Medical Purposes for Diabetes Production Mode & Process
  6. 9.2 Formulas for Special Medical Purposes for Diabetes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Formulas for Special Medical Purposes for Diabetes Distributors
  9. 9.2.3 Formulas for Special Medical Purposes for Diabetes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst